Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Cited by (288)

Items 101–200 of 288

1. Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells
   Lokman Varışlı, Ceren Gonen‐Korkmaz, Hamid Syed Muhammed, Nuray Böğürcü, Bilge DEBELEÇ BÜTÜNER, Burcu Erbaykent Tepedelen, Kemal Korkmaz · 2011 · Molecular and Cellular Endocrinology
2. The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer
   Yue Zhao, Xin Hu, Haoran Yu, Huimin Sun, Lei Zhang, Chen Shao · 2024 · Research
3. In vivo biomarker expression patterns are preserved in 3D cultures of Prostate Cancer
   Louisa C. E. Windus, Debra L. Kiss, Tristan T Glover, Vicky M. Avery · 2012 · Experimental Cell Research
4. PAGE4 Positivity Is Associated with Attenuated AR Signaling and Predicts Patient Survival in Hormone-Naive Prostate Cancer
   Natalie Sampson, Christian Felipe Ruiz, Christoph Zenzmaier, Lukas Bubendorf, Peter Berger · 2012 · American Journal Of Pathology
5. Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models
   Rachel M. Squillace, DAVID MILLER, Scott Wardwell, Frank Wang, Tim Clackson, Victor M. Rivera · 2012 · International Journal of Oncology
6. Stromal Activation Associated with Development of Prostate Cancer in Prostate-Targeted Fibroblast Growth Factor 8b Transgenic Mice
   Teresa Elo, Eeva M. Valve, Jani Seppänen, Heikki Vuorikoski, Sari Mäkelä, Matti H. POUTANEN, Paula M. Kujala, Pirkko L. Härkönen · 2010 · Neoplasia
7. Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate
   William Nathaniel Brennen, Baohui Zhang, İbrahim Kulaç, L. Nelleke Kisteman, Lizamma Antony, Hao Wang, Alan Keith Meeker, Angelo Michael De Marzo, Isla P. Garraway, Samuel Ray Denmeade et al. · 2017 · Oncotarget
8. Immunohistochemical detection of tyrosine phosphatase SHP‐1 predicts outcome after radical prostatectomy for localized prostate cancer
   Helena Tassidis, Leon J. S. Brokken, Karin Jirström, Roy A. Ehrnström, Fredrik Pontén, David Ulmert, Anders S Bjartell, Pirkko L. Härkönen, Anette Gjörloff Wingren · 2009 · International Journal of Cancer
9. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors
   Lescarbeau, Reynald M., Seib, F. Philipp, Prewitz, Marina, Werner, Carsten, Kaplan, David L. · 2012 · PLoS ONE
10. Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R)
    Izabela Sokolowska, Alisa G. Woods, Mary Ann Gawinowicz, Urmi Roy, Costel C. Darie · 2012 · Cellular and Molecular Life Sciences
11. A Potential Role and Contribution of Androgens in Placental Development and Pregnancy
    Agata M. Parsons, Gerrit J. Bouma · 2021 · Life
12. The Nuclear Translocation of Heme Oxygenase-1 in Human Diseases
    Qing Yang, Wenqian Wang · 2022 · Frontiers in Cell and Developmental Biology
13. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia
    Takeo Nomura, Mutsushi Yamasaki, Kenichi Hirai, Toru Inoue, Ryuta Sato, Keiko Matsuura, Masatsugu Moriyama, Fuminori Sato, Hiromitsu Mimata · 2013 · Molecular Cancer
14. Dihydrotestosterone Induces Proliferation, Migration, and Invasion of Human Glioblastoma Cell Lines
    Dulce Carolina Rodríguez-Lozano, Diana Elisa Velázquez-Vázquez, Aylin Del Moral‐Morales, Ignacio Camacho‐Arroyo · 2020 · OncoTargets and Therapy
15. The Pathogenesis of Prostate Cancer
    Toby B. J. Murray · 2021 · Exon Publications eBooks
16. TGF-β Uses the E3-Ligase TRAF6 to Turn on the Kinase TAK1 to Kill Prostate Cancer Cells
    Noopur Thakur, Alessandro Sorrentino, Carl‐Henrik Heldin, Maréne Landström · 2009 · Future Oncology
17. Androgen‐induced PSA expression requires not only activation of AR but also endogenous IGF‐I or IGF‐I/PI3K/Akt signaling in human prostate cancer epithelial cells
    Xunxian Liu, Renee Y. Choi, Shayma Jawad, Julia T. Arnold · 2010 · The Prostate
18. Role of Heparan Sulfate 2-O-Sulfotransferase in Prostate Cancer Cell Proliferation, Invasion, and Growth Factor Signaling
    Brent W. Ferguson, Sumana Datta · 2011 · Prostate Cancer
19. Effects of Tribulus terrestris saponins on exercise performance in overtraining rats and the underlying mechanisms
    Liang Yin, Qian Wang, Xiaohui Wang, Liang‐Nian Song · 2016 · Canadian Journal of Physiology and Pharmacology
20. Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate
    Kenichiro Ishii, Sanai Takahashi, Yoshiki Sugimura, Masatoshi Watanabe · 2018 · Journal of Clinical Medicine
21. Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
    Estefanía Labanca, Jun Yang, Peter D.A. Shepherd, Xinhai Wan, Michael W. Starbuck, Leah D. Guerra, Nicolás Anselmino, Juan Antonio Bizzotto, Jiabin Dong, Arul M. Chinnaiyan et al. · 2021 · European Urology Oncology
22. Leptin signaling and apoptotic effects in human prostate cancer cell lines
    Sigal Samuel‐Mendelsohn, Michal Inbar, Esther Weiss‐Messer, Leonora Niv‐Spector, Arieh Gertler, Ronnie J. Barkey · 2010 · The Prostate
23. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer
    Joice Rocha, Fatima Z. Zouanat, Amina Zoubeidi, L. Hamel, Tarik Benidir, Eleonora Scarlata, Fadi Brimo, Armen Garo Aprikian, Simone Chevalier · 2013 · Molecular and Cellular Endocrinology
24. Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer.
    Federica Recine, Cora Nanette Sternberg · 2015 · PubMed Central
25. Broadening horizons in medical management of prostate cancer
    Saroj Niraula, Ian F. Tannock · 2011 · Acta Oncologica
26. The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer
    Melanie Kirkby, Alyanna M. Popatia, Jessie R. Lavoie, Lisheng Wang · 2023 · Cancers
27. 7-epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cells
    David Díaz-Carballo, Sebastian Gustmann, Ali Haydar Acikelli, Walter Bardenheuer, Helmut Buehler, Holger Jastrow, Süleyman Ergün, Dirk Strumberg · 2012 · Phytomedicine
28. Discovery and Mechanistic Characterization of a Novel Selective Nuclear Androgen Receptor Exporter for the Treatment of Prostate Cancer
    Ramesh Narayanan, Muralimohan Yepuru, Adam T. Szafran, Maria M. Szwarc, Casey E. Bohl, Natalie L. Young, Duane D. Miller, Michael A. Mancini, James T. Dalton · 2010 · Cancer Research
29. Active G protein–coupled receptors (GPCR), matrix metalloproteinases 2/9 (MMP2/9), heparin-binding epidermal growth factor (hbEGF), epidermal growth factor receptor (EGFR), erbB2, and insulin-like growth factor 1 receptor (IGF-1R) are necessary for trenbolone acetate–induced alterations in protein turnover rate of fused bovine satellite cell cultures1
    Kara J Thornton, E. Kamanga‐Sollo, Margaret E. White, William Randall Dayton · 2016 · Journal of Animal Science
30. Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
    Pierangela Sepe, Elena Verzoni, Patrizia Miodini, Mélanie Claps, Raffaele Ratta, Antonia Martinetti, Roberta Mennitto, Elisa Sottotetti, Giuseppe Procopio, Vera Cappelletti et al. · 2019 · Cancers
31. Emerging Targeted Therapies for Castration-Resistant Prostate Cancer
    Vincenzo Adamo, Laura Noto, Tindara Franchina, G. Chiofalo, Maria Picciotto, Giuseppe Toscano, N. Caristi · 2012 · Frontiers in Endocrinology
32. Effects of red ginseng oil(KGC11o) on testosterone-propionate-induced benign prostatic hyperplasia
    Jeong Yoon Lee, Sohyuk Kim, Seokho Kim, Jong Han Kim, Bong Seok Bae, Gi‐Bang Koo, Seung-Ho So, Jeongmin Lee, Yoo‐Hyun Lee · 2021 · Journal of Ginseng Research
33. Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer
    Renjith P. Johnson, Chandrahas Koumar Ratnacaram, Lalit Kumar, Jobin Jose · 2022 · Drug Resistance Updates
34. Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach
    Raquel Fernandes, Cátia Costa, Rúben Fernandes, Ana Barros · 2023 · Biomedicines
35. Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitro
    Pushpendra Singh, Felix Bast · 2015 · Medical Oncology
36. Regulation of TGF-β1 expression by Androgen Deprivation Therapy of prostate cancer
    Paolo Fuzio, Pasquale Ditonno, Monica Rutigliano, Michele Battaglia, Carlo Bettocchi, Antonia Loverre, Giuseppe Grandaliano, Elda Perlino · 2011 · Cancer Letters
37. Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen‐independent progression
    Kiyoshi Takahara, Howard Tearle, Mazyar Ghaffari, Martin Edwin Gleave, Michaël Pollak, Michael Cox · 2010 · The Prostate
38. Current state of castration-resistant prostate cancer.
    Daniel Peter Petrylak · 2013 · PubMed
39. HORMONAL IMPACT ON TUMOR GROWTH AND PROGRESSION
    А. Г. Резніков · 2015 · Experimental Oncology
40. CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells
    Yeqing Yuan, Zhengzuo Sheng, Zhenhua Liu, Xiaowei Zhang, Yunbei Xiao, Jing Xie, Yixiang Zhang, Tao Xu · 2020 · Journal of Cancer
41. Conjugated and non-conjugated androgens differentially modulate specific early gene transcription in breast cancer in a cell-specific manner
    George Notas, Vasiliki Pelekanou, Elias Castanas, Marilena Kampa · 2009 · Steroids
42. Insulin/IGF1 signaling regulates the mitochondrial biogenesis markers in steroidogenic cells of prepubertal testis, but not ovary†
    Sava M. Radovic Pletikosic, Isidora M. Starovlah, Ivan Čapo, Dejan Miljković, Serge Nef, Tatjana S. Kostic, Silvana A. Andrić · 2018 · Biology of Reproduction
43. Regulation of growth hormone receptors in human prostate cancer cell lines
    Maslama Bidosee, Rachel Karry, Esther Weiss‐Messer, Ronnie J. Barkey · 2009 · Molecular and Cellular Endocrinology
44. Analysis of Transcriptome, Selected Intracellular Signaling Pathways, Proliferation and Apoptosis of LNCaP Cells Exposed to High Leptin Concentrations
    Marta Szyszka, Lukasz Paschke, Marianna Tyczewska, Karol Jopek, Piotr Celichowski, Paulina Milecka, Gulnar Sultanova, Ewelina Stelcer, Agnieszka Malińska, Ludwik K. Malendowicz et al. · 2019 · International Journal of Molecular Sciences
45. Carbidopa abrogates L ‐dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression
    Latif A. Wafa, Helen Cheng, Nathan Plaa, Fariba Ghaidi, Takahiro Fukumoto, Ladan Fazli, Martin Edwin Gleave, Michael Cox, Paul S. Rennie · 2011 · International Journal of Cancer
46. Androgen receptor and miR-206 regulation in prostate cancer
    Fu Yee Chua, Brian D. Adams · 2017 · Transcription
47. Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones
    Maja Marklund, Niklas Schultz, Stefanie Friedrich, Emelie Berglund, Firas Tarish, Anna Tanoglidi, Yao Liu, Ludvig Bergenstråhle, Andrew M. Erickson, Thomas Helleday et al. · 2022 · Nature Communications
48. The miRNA let-7a1 inhibits the expression of insulin-like growth factor 1 receptor (IGF1R) in prostate cancer PC-3 cells
    Lina Wang, Weiwen Chen, Ju Zhang, Chaoyang Li, Chunyan Liu, Jing Xue, Pengju Zhang, An-Li Jiang · 2013 · Asian Journal of Andrology
49. Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell lines
    Rumi Kawabata · 2011 · International Journal of Oncology
50. Loss of epithelial AR increase castration resistant stem-like prostate cancer cells and promotes cancer metastasis via TGF-β1/EMT pathway
    Qiliang Cai, Yegang Chen, Dingnrong Zhang, Jiancheng Pan, Zunke Xie, Shenze Ma, Chuanfeng Liu, Jiquan Zuo, Xiaodong Zhou, Changyi Quan et al. · 2020 · Translational Andrology and Urology
51. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations
    Eman Maher Elbaz, Alshaymaa Darwish, Amany M. Gad, Amina A. S. Abdel Rahman, Maheera H. Safwat · 2023 · European Journal of Pharmacology
52. Reduced Graphene Oxide Decorated with AuNPs as a New Aptamer-Based Biosensor for the Detection of Androgen Receptor from Prostate Cells
    Bruno Pereira Crulhas, Caroline Rodrigues Basso, João P. R. L. L. Parra, Gustavo R. Castro, Valber A. Pedrosa · 2019 · Journal of Sensors
53. Alpha Satellite RNA Levels Are Upregulated in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
    Sven Ljubić, Antonio Sermek, Angela Prgomet Sečan, Marin Prpić, Blanka Jakšić, Jure Murgić, Ana Fröbe, Đurđica Ugarković, Isidoro Feliciello · 2022 · Genes
54. Pathogenesis of prostate cancer: lessons from basic research.
    Vamsidhar Velcheti, Satish Karnik, Stephen F. Bardot, Om Prakash · 2008 · PubMed Central
55. Antitumoral action of icaritin in LNCaP prostate cancer cells by regulating PEA3/HER2/AR signaling
    Jimeng Hu, Wenhui Zhu, Bingbing Wei, Hui Wen, Shanhua Mao, Hua Xu, Mengbo Hu, Tian Yang, Haowen Jiang · 2016 · Anti-Cancer Drugs
56. Androgen receptor is widely expressed in bovine placentomes and up-regulated during differentiation of bovine trophoblast giant cells
    P. Khatri, Bernd Hoffmann, Gerhard C Schuler · 2013 · Placenta
57. Intracellular adaptor molecules and AR signalling in the tumour microenvironment
    Vikash Reebye, Andrea Frilling, Nagy Adley Habib, Paul J. Mintz · 2010 · Cellular Signalling
58. Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer
    Hongxi Wu, Lulu Zhang, Xiaofang Gao, Xiuna Zhang, Jingjing Duan, Linjun You, Yan Cheng, Jin‐Song Bian, Qingyi Zhu, Yong Yang · 2016 · Cancer Letters
59. Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance
    Md Imtiaz Khalil, Arrigo De Benedetti · 2022 · Cancer Drug Resistance
60. Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer
    David T. Hoang, Lei Gu, Zhiyong Liao, Feng Shen, Pooja G. Talati, Mateusz Koptyra, Shyh‐Han Tan, Elyse Ellsworth, Shilpa Gupta, Heather L. Montie et al. · 2015 · Molecular Cancer Therapeutics
61. Targeting treatment options for castration-resistant prostate cancer.
    Dannah R. Miller, Matthew A. Ingersoll, Benjamin A. Teply, Ming‐Fong Lin · 2021 · PubMed Central
62. Hexim‐1 modulates androgen receptor and the TGF‐β signaling during the progression of prostate cancer
    Eduardo J. Mascareno, Ivan A. Belashov, M.A.Q. Siddiqui, Fang Liu, Manya Dhar-Mascareño · 2011 · The Prostate
63. Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate
    Fei Su, Bruna Corrêa, Jianhua Luo, Ricardo Z. N. Vêncio, Laura E. Pascal, Zhou Wang · 2013 · Cancer Microenvironment
64. Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer
    Takeshi Sasaki, Kenichiro Ishii, Yoichi Iwamoto, Manabu Kato, Manabu Miki, Hideki Kanda, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura · 2015 · Laboratory Investigation
65. Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells
    Alexandra M. Fajardo, Debra A. MacKenzie, Sarah L. Olguin, J. K. Scariano, Ian Rabinowitz, Todd A. Thompson · 2016 · PLoS ONE
66. Suppressive Effect and Molecular Mechanism of Houttuynia cordata Thunb. Extract against Prostate Carcinogenesis and Castration-Resistant Prostate Cancer
    Subhawat Subhawa, Aya Naiki‐Ito, Hiroyuki Kato, Taku Naiki, Masayuki Komura, Aya Nagano-Matsuo, Ranchana Yeewa, Shingo Inaguma, Teera Chewonarin, Ratana Banjerdpongchai et al. · 2021 · Cancers
67. Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
    Belén Congregado Ruiz, Ines RIVERO BELENCHON, Guillermo Lendinez Cano, Rafael Antonio Medina López · 2023 · Biomedicines
68. Interaction between insulin and androgen signalling in decidualization, cell migration and trophoblast invasion in vitro
    Angelica Lindén Hirschberg, Ivika Jakson, Carlota Graells Brugalla, Dániel Salamon, Dorina Ujvári · 2021 · Journal of Cellular and Molecular Medicine
69. PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia
    Kim Parker, Antonio Berretta, Stefanie Saenger, Manaswini Sivaramakrishnan, Simon A. Shirley, Friedrich Metzger, Andrew N. Clarkson · 2017 · Scientific Reports
70. GPCR-Gα13 Involvement in Mitochondrial Function, Oxidative Stress, and Prostate Cancer
    Di Wu, Patrick J. Casey · 2024 · International Journal of Molecular Sciences
71. A Standardized Wedelia chinensis Extract Overcomes the Feedback Activation of HER2/3 Signaling upon Androgen-Ablation in Prostate Cancer
    Chin-Hsien Tsai, Sheue‐Fen Tzeng, Shih-Chuan Hsieh, Chia-Jui Tsai, Yu‐Chih Yang, Mong‐Hsun Tsai, Pei‐Wen Hsiao · 2017 · Frontiers in Pharmacology
72. Contribution of the unfolded protein response to breast and prostate tissue homeostasis and its significance to cancer endocrine response
    Inês Direito, Margarida Fardilha, Luisa Alejandra Helguero · 2018 · Carcinogenesis
73. Targeting Prostate Cancer, the ‘Tousled Way’
    Siddhant Bhoir, Arrigo De Benedetti · 2023 · International Journal of Molecular Sciences
74. Increased androgen receptor levels and signaling in ovarian cancer cells by VEPH1 associated with suppression of SMAD3 and AKT activation
    Alexandra Kollara, Premalatha Shathasivam, Soyeon Park, Maurice Joseph Ringuette, Theodore J. Brown · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
75. H19 in Serum Extracellular Vesicles Reflects Resistance to AR Axis-targeted Therapy Among CRPC Patients
    Taku Kato, Kyojiro Kawakami, Kosuke Mizutani, TATSUYA ANDO, Yasuhiro Sakai, Kouhei Sakurai, Shohei Toyota, Hidetoshi Ehara, Hiroyasu Ito, Masafumi Ito · 2023 · Cancer Genomics & Proteomics
76. Bisbibenzyls, novel proteasome inhibitors, suppress androgen receptor transcriptional activity and expression accompanied by activation of autophagy in prostate cancer LNCaP cells
    Zhongyi Hu, Denglu Zhang, Dawei Wang, Bin Sun, Ayesha Safoor, Charles Y.F. Young, Hong‐Xiang Lou, Huiqing Yuan · 2015 · Pharmaceutical Biology
77. miR-34C Disrupts the Stemness of Purified CD133 + Prostatic Cancer Stem Cells
    Yuan Chen, Qun Xian Rao, Huiping Zhang, Hua Xu, Cuntai Zhang, Qianyuan Zhuang, Zhangqun Ye · 2016 · Urology
78. An androgen-regulated miR-2909 modulates TGFβ signalling through AR/miR-2909 axis in prostate cancer
    Shiekh Gazalla Ayub, Deepak Kaul, Taha Ayub · 2017 · Gene
79. A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer
    Derek J. Rosario, Rosa Greasley, Mohammad Khabazhaitajer · 2015 · Cancer Management and Research
80. Kuguacin J, a Triterpenoid from Momordica charantia Linn: A Comprehensive Review of Anticarcinogenic Properties
    Pornngarm Limtrakul, Pornsiri Pitchakarn, Shugo Suzuki · 2013 · InTech eBooks
81. The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer
    Michael William Drazer, Walter Michael Stadler · 2016 · The Cancer Journal
82. Emerging role of transforming growth factor-β-regulated long non-coding RNAs in prostate cancer pathogenesis
    Bakhya Shree, Koyel Das, Vivek Sharma · 2022 · Cancer Pathogenesis and Therapy
83. Near-infrared targeted EGFR fluorescent probe for tumor imaging and diagnosis
    Wenjing Huang, Li Wang, Hao Zhang, Zhihao Han, Yueqing Gu · 2023 · Sensors and Actuators B Chemical
84. Beyond abiraterone
    Álvaro Pinto · 2013 · Cancer Biology & Therapy
85. Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling
    Reynald M. Lescarbeau, David Lee Kaplan · 2014 · BMC Cancer
86. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells
    Awatef Ben Jemaa, Satâa Sallami, Jocelyn Céraline, Ridha Oueslati · 2013 · Cell Biology International
87. A Comparison of the Biological Features of Prostate Cancer with (PSA+, PSMA+) Profile according to RKIP
    Awatef Ben Jemaa, Yosra Bouraoui, Satâa Sallami, Yassine Nouira, Ridha Oueslati · 2013 · BioMed Research International
88. JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer
    Jogendra Singh Pawar, Md. Yusuf Al-Amin, Chang‐Deng Hu · 2023 · Frontiers in Oncology
89. Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective
    Lokman Varışlı, Veysel Tolan, JIYAN H. CEN, Spiros Vlahopoulos, Osman Çen · 2022 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
90. In vitro and In vivo oxidation and cleavage products of tocols: From chemical tuners to “VitaminEome” therapeutics. A narrative review
    Farid Khallouki, Somayya Saber, Toufik Bouddine, Lhoussain Hajji, Bachir Elbouhali, Sandrine Silvente‐Poirot, Marc Poirot · 2022 · Food Bioscience
91. Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis
    Jani Silva, Valéria Tavares, Ana Afonso, Juliana Garcia, Fátima Cerqueira, Rui Medeiros · 2023 · International Journal of Molecular Sciences
92. Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancer
    Vikash Reebye, Charlotte Lynne Bevan, Mahrokh Nohadani, Amin Hajitou, Nagy Adley Habib, Paul J. Mintz · 2010 · Cellular Signalling
93. Gastrin‐releasing peptide: Predictor of castration‐resistant prostate cancer?
    Elmar Heinrich, Kai Alexander Probst, Maurice Stephan Michel, Lutz Trojan · 2010 · The Prostate
94. Effect of Oncostatin M on Uridine Diphosphate-5′-Glucuronosyltransferase 1A1 through Cross Talk with Constitutive Androstane Receptor
    Hisashi Masuyama, Hideki Nakatsukasa, Yuji Hiramatsu · 2010 · Molecular Endocrinology
95. Expression and regulation of aldehyde dehydrogenases in prostate cancer
    Ali I. M. Ibrahim, Maria Sadiq, Fiona M. Frame, Norman J. Maitland, Klaus Pors · 2018 · Journal of Cancer Metastasis and Treatment
96. The safety and efficacy of CAR-T cells in the treatment of prostate cancer: review
    Othman Mohammad Saleh, Khaled Anwer Albakri, Yasmeen Jamal Alabdallat, Majd Dajani, Walaa Bayoumie El Gazzar · 2021 · Biomarkers
97. High prevalence of benign mammary tumors in a rat model of polycystic ovary syndrome during postmenopausal period
    Mahsa Noroozzadeh, Samira Behboudi‐Gandevani, Nariman Mosaffa, Maryam Tohidi, Fahimeh Ramezani Tehrani · 2019 · Gynecological Endocrinology
98. Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration
    Kenichiro Ishii, Izumi Matsuoka, Takeshi Sasaki, Kohei Nishikawa, Hideki Kanda, Hiroshi Imai, YOSHIFUMI S. HIROKAWA, Kazuhiro Iguchi, Kiminobu Arima, Yoshiki Sugimura · 2019 · Journal of Clinical Medicine
99. Stromal-AR influences the growth of epithelial cells in the development of benign prostate hyperplasia
    Gaurav Chauhan, Avani Mehta, Sarita S. Gupta · 2020 · Molecular and Cellular Biochemistry
100. Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients
     Spyridon Sideris, Fouad Y. Aoun, C. N. Martinez, Sofiya Latifyan, Ahmad Hussein Awada, Giuseppe Costante, Thierry Gil · 2016 · Journal of Endocrinological Investigation